MyFinsight
Home
Blog
About
Contact
Download
Download image
North American
Pharmaceutical...
$88,322M
Oncology And
Multispecialty...
$13,010M
Medical Surgical
Solutions...
$2,991M
Operating
Segments-Prescription Technology...
$1,500M
Material Reconciling
Items
$335M
Revenues
$106,158M
(11.40%↑ Y/Y)
Gross profit
$3,685M
(12.21%↑ Y/Y)
Cost of sales
$102,473M
(11.37%↑ Y/Y)
Operating income
$1,619M
(32.27%↑ Y/Y)
Other income, net
$74M
(7.25%↑ Y/Y)
Total operating
expenses
$2,066M
(0.29%↑ Y/Y)
Income before income
taxes
$1,630M
(32.95%↑ Y/Y)
Interest expense
$63M
(-5.97%↓ Y/Y)
Selling, distribution,
general, and...
$2,030M
(0.10%↑ Y/Y)
Restructuring, impairment, and
related charges, net
$36M
(12.50%↑ Y/Y)
Net income
$1,250M
(34.70%↑ Y/Y)
Income tax expense
$380M
(27.52%↑ Y/Y)
Net income
attributable to mckesson...
$1,186M
(34.93%↑ Y/Y)
Net income
attributable to...
$64M
(30.61%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
mck_logo_blue-svg
MCKESSON CORP (MCK)
mck_logo_blue-svg
MCKESSON CORP (MCK)